Pressure BioSciences, Inc. Discusses Research Mark
Post# of 1354
LOS ANGELES, Feb. 8, 2017 /PRNewswire/ -- StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded on Thursday, December 8th, 2016 at the LD Micro "Main Event" 2016 in Bel Air, CA.
Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:
Update with Pressure BioSciences, Inc. – Discusses Research Market, Goals and Milestones for First Half of 2017
You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN, YOUTUBE, and STOCKTWITS
Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. ("PBI" (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and forensic applications.
For more information, visit: http://www.PressureBioSciences.com
About StockNewsNow.com
StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.
Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for - all here on StockNewsNow.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pressure-biosciences-inc-discusses-research-market-goals-an
d-milestones-for-first-half-of-2017-in-new-snnlive-video-interview-with-stocknewsnowcom-300404065.html
SOURCE StockNewsNow.com
Copyright © 2017 PR Newswire. All Rights Reserved
http://www.prnewswire.com/news-releases/press...t-goals-an
d-milestones-for-first-half-of-2017-in-new-snnlive-video-interview-with-stocknewsnowcom-300404065.html